CVD-21: A novel instrument for predicting and monitoring cardiovascular disease

Researchers at Uppsala University have developed an instrument that makes it possible to measure 21 biomarkers for cardiovascular disease simultaneously with great precision by means of a simple blood test.

Revance weighs competing buyout offer amid push from original bidder

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 9, 2025

Boundless Bio raises $100m as IPO market rouses – Pharmaceutical Technology

Share this article The IPO market is rebounding, with several pharma companies already listing this year. Image credit: Shutterstock/kenary820. US-based Boundless Bio will offer 6,250,000

March 28, 2024

Report Reveals Pharmacies Poised for Expansion: Consumers Open to Broader Clinical Services

What You Should Know: – A recent survey by Outcomes Operating, Inc., a leader in pharmacy workflow solutions, paints a clear picture: consumers are ready

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.